Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells

K. H. Cowan, M. E. Goldsmith, R. M. Levine, S. C. Aitken, E. Douglass, N. Clendeninn, A. W. Nienhuis, Marc E Lippman

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Methotrexate-resistance (MTX(R)) human breast cancer cells have been obtained which are 1000-fold less sensitive to this drug than the wild type MCF-7 cells from which they were derived. The resistant cells contain approximately a 25-fold increase in the activity of the target enzyme dihydrofolate (DHF) reductase. Enzyme inhibition studies and methotrexate affinity studies fail to reveal any difference in the DHF reductase present in the MTX(R) cells compared to wild type MCF-7 cells. Cytogenetic analysis demonstrates the presence of elongated marker chromosomes in the resistant cells which are not found in the parental cell line. Analysis of the DNA from MTX(R) and wild type MCF-7 cells using Southern blot hybridization indicates that the MTX(R) MCF-7 cells contain more copies of DHF reductase gene sequences than do wild type MCF-7 cells. These experiments also suggest that the amplified DHF reductase gene sequences in MTX(R) cells may have undergone a uniform structural rearrangement involving the 5' flanking sequences during the process of amplification. MTX(R) MCF-7 cells respond to estradiol by increasing cell growth, and the level of DHF reductase in the MTX(R) cells is further induced following administration of estradiol. Radiolabeling studies demonstrate that estrogen stimulates the actual synthesis of DHF reductase in human breast cancer cells.

Original languageEnglish
Pages (from-to)15079-15086
Number of pages8
JournalJournal of Biological Chemistry
Volume257
Issue number24
StatePublished - Dec 1 1982
Externally publishedYes

Fingerprint

Tetrahydrofolate Dehydrogenase
Gene Amplification
Methotrexate
MCF-7 Cells
Estrogens
Cells
Breast Neoplasms
Estradiol
Genes
Enzyme inhibition
5' Flanking Region
Cell growth
Chromosomes
Amplification
Cytogenetic Analysis
Enzymes
Southern Blotting
Genetic Markers
DNA
Cell Line

ASJC Scopus subject areas

  • Biochemistry

Cite this

Cowan, K. H., Goldsmith, M. E., Levine, R. M., Aitken, S. C., Douglass, E., Clendeninn, N., ... Lippman, M. E. (1982). Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. Journal of Biological Chemistry, 257(24), 15079-15086.

Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. / Cowan, K. H.; Goldsmith, M. E.; Levine, R. M.; Aitken, S. C.; Douglass, E.; Clendeninn, N.; Nienhuis, A. W.; Lippman, Marc E.

In: Journal of Biological Chemistry, Vol. 257, No. 24, 01.12.1982, p. 15079-15086.

Research output: Contribution to journalArticle

Cowan, KH, Goldsmith, ME, Levine, RM, Aitken, SC, Douglass, E, Clendeninn, N, Nienhuis, AW & Lippman, ME 1982, 'Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells', Journal of Biological Chemistry, vol. 257, no. 24, pp. 15079-15086.
Cowan, K. H. ; Goldsmith, M. E. ; Levine, R. M. ; Aitken, S. C. ; Douglass, E. ; Clendeninn, N. ; Nienhuis, A. W. ; Lippman, Marc E. / Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. In: Journal of Biological Chemistry. 1982 ; Vol. 257, No. 24. pp. 15079-15086.
@article{f28d27ad2cae40619979077c9cf59573,
title = "Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells",
abstract = "Methotrexate-resistance (MTX(R)) human breast cancer cells have been obtained which are 1000-fold less sensitive to this drug than the wild type MCF-7 cells from which they were derived. The resistant cells contain approximately a 25-fold increase in the activity of the target enzyme dihydrofolate (DHF) reductase. Enzyme inhibition studies and methotrexate affinity studies fail to reveal any difference in the DHF reductase present in the MTX(R) cells compared to wild type MCF-7 cells. Cytogenetic analysis demonstrates the presence of elongated marker chromosomes in the resistant cells which are not found in the parental cell line. Analysis of the DNA from MTX(R) and wild type MCF-7 cells using Southern blot hybridization indicates that the MTX(R) MCF-7 cells contain more copies of DHF reductase gene sequences than do wild type MCF-7 cells. These experiments also suggest that the amplified DHF reductase gene sequences in MTX(R) cells may have undergone a uniform structural rearrangement involving the 5' flanking sequences during the process of amplification. MTX(R) MCF-7 cells respond to estradiol by increasing cell growth, and the level of DHF reductase in the MTX(R) cells is further induced following administration of estradiol. Radiolabeling studies demonstrate that estrogen stimulates the actual synthesis of DHF reductase in human breast cancer cells.",
author = "Cowan, {K. H.} and Goldsmith, {M. E.} and Levine, {R. M.} and Aitken, {S. C.} and E. Douglass and N. Clendeninn and Nienhuis, {A. W.} and Lippman, {Marc E}",
year = "1982",
month = "12",
day = "1",
language = "English",
volume = "257",
pages = "15079--15086",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "24",

}

TY - JOUR

T1 - Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells

AU - Cowan, K. H.

AU - Goldsmith, M. E.

AU - Levine, R. M.

AU - Aitken, S. C.

AU - Douglass, E.

AU - Clendeninn, N.

AU - Nienhuis, A. W.

AU - Lippman, Marc E

PY - 1982/12/1

Y1 - 1982/12/1

N2 - Methotrexate-resistance (MTX(R)) human breast cancer cells have been obtained which are 1000-fold less sensitive to this drug than the wild type MCF-7 cells from which they were derived. The resistant cells contain approximately a 25-fold increase in the activity of the target enzyme dihydrofolate (DHF) reductase. Enzyme inhibition studies and methotrexate affinity studies fail to reveal any difference in the DHF reductase present in the MTX(R) cells compared to wild type MCF-7 cells. Cytogenetic analysis demonstrates the presence of elongated marker chromosomes in the resistant cells which are not found in the parental cell line. Analysis of the DNA from MTX(R) and wild type MCF-7 cells using Southern blot hybridization indicates that the MTX(R) MCF-7 cells contain more copies of DHF reductase gene sequences than do wild type MCF-7 cells. These experiments also suggest that the amplified DHF reductase gene sequences in MTX(R) cells may have undergone a uniform structural rearrangement involving the 5' flanking sequences during the process of amplification. MTX(R) MCF-7 cells respond to estradiol by increasing cell growth, and the level of DHF reductase in the MTX(R) cells is further induced following administration of estradiol. Radiolabeling studies demonstrate that estrogen stimulates the actual synthesis of DHF reductase in human breast cancer cells.

AB - Methotrexate-resistance (MTX(R)) human breast cancer cells have been obtained which are 1000-fold less sensitive to this drug than the wild type MCF-7 cells from which they were derived. The resistant cells contain approximately a 25-fold increase in the activity of the target enzyme dihydrofolate (DHF) reductase. Enzyme inhibition studies and methotrexate affinity studies fail to reveal any difference in the DHF reductase present in the MTX(R) cells compared to wild type MCF-7 cells. Cytogenetic analysis demonstrates the presence of elongated marker chromosomes in the resistant cells which are not found in the parental cell line. Analysis of the DNA from MTX(R) and wild type MCF-7 cells using Southern blot hybridization indicates that the MTX(R) MCF-7 cells contain more copies of DHF reductase gene sequences than do wild type MCF-7 cells. These experiments also suggest that the amplified DHF reductase gene sequences in MTX(R) cells may have undergone a uniform structural rearrangement involving the 5' flanking sequences during the process of amplification. MTX(R) MCF-7 cells respond to estradiol by increasing cell growth, and the level of DHF reductase in the MTX(R) cells is further induced following administration of estradiol. Radiolabeling studies demonstrate that estrogen stimulates the actual synthesis of DHF reductase in human breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=0020355516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020355516&partnerID=8YFLogxK

M3 - Article

VL - 257

SP - 15079

EP - 15086

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 24

ER -